| Megan Steinwagner Lcsw Llc | |
|
3121 Atlantic Ave Allenwood NJ 08720-7009 | |
| (848) 863-7941 | |
| Not Available |
| Full Name | Megan Steinwagner Lcsw Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 3121 Atlantic Ave, Allenwood, New Jersey |
| Authorized Official Name and Position | Megan Steinwagner (OWNER) |
| Authorized Official Contact | 7326841922 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Steinwagner Lcsw Llc 25 Lake Dr Howell NJ 07731-1524 Ph: (732) 684-1922 | Megan Steinwagner Lcsw Llc 3121 Atlantic Ave Allenwood NJ 08720-7009 Ph: (848) 863-7941 |
| NPI Number | 1467047993 |
|---|---|
| Provider Enumeration Date | 03/06/2021 |
| Last Update Date | 03/06/2021 |
| Certification Date | 03/06/2021 |
| Medicare PECOS PAC ID | 2668880923 |
|---|---|
| Medicare Enrollment ID | O20210426002674 |
News Archive
Researchers at Oregon State University today announced an important advance in the field of cancer imaging and phototherapy, using a single-agent system that may ultimately change the efficacy of cancer surgery and treatment around the world.
Alzheimer's remains the leading cause of dementia in Western societies, with some estimates suggesting that as many as 24 million people worldwide are living with the disease.
Precision cancer medicine - diagnosis and treatment based on the genetic abnormalities of a specific tumor - is playing an ever-larger role in cancer care. The field got a boost earlier this year when President Barack Obama proposed a $215 million federal Precision Medicine Initiative with cancer as one of its priorities.
The decline in hospital readmission rates that occurred following the launch of a federal program designed to improve quality of care and reduce repeat hospitalizations has been lauded as proof of the program's effectiveness.
An experimental device converted energy from a beating heart to provide enough electricity to power a pacemaker, in a study presented at the American Heart Association's Scientific Sessions 2012.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467047993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
| Provider Name | Megan Steinwagner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1487084539 PECOS PAC ID: 8224447776 Enrollment ID: I20210421001933 |
News Archive
Researchers at Oregon State University today announced an important advance in the field of cancer imaging and phototherapy, using a single-agent system that may ultimately change the efficacy of cancer surgery and treatment around the world.
Alzheimer's remains the leading cause of dementia in Western societies, with some estimates suggesting that as many as 24 million people worldwide are living with the disease.
Precision cancer medicine - diagnosis and treatment based on the genetic abnormalities of a specific tumor - is playing an ever-larger role in cancer care. The field got a boost earlier this year when President Barack Obama proposed a $215 million federal Precision Medicine Initiative with cancer as one of its priorities.
The decline in hospital readmission rates that occurred following the launch of a federal program designed to improve quality of care and reduce repeat hospitalizations has been lauded as proof of the program's effectiveness.
An experimental device converted energy from a beating heart to provide enough electricity to power a pacemaker, in a study presented at the American Heart Association's Scientific Sessions 2012.
› Verified 1 days ago
News Archive
Researchers at Oregon State University today announced an important advance in the field of cancer imaging and phototherapy, using a single-agent system that may ultimately change the efficacy of cancer surgery and treatment around the world.
Alzheimer's remains the leading cause of dementia in Western societies, with some estimates suggesting that as many as 24 million people worldwide are living with the disease.
Precision cancer medicine - diagnosis and treatment based on the genetic abnormalities of a specific tumor - is playing an ever-larger role in cancer care. The field got a boost earlier this year when President Barack Obama proposed a $215 million federal Precision Medicine Initiative with cancer as one of its priorities.
The decline in hospital readmission rates that occurred following the launch of a federal program designed to improve quality of care and reduce repeat hospitalizations has been lauded as proof of the program's effectiveness.
An experimental device converted energy from a beating heart to provide enough electricity to power a pacemaker, in a study presented at the American Heart Association's Scientific Sessions 2012.
› Verified 1 days ago